Read all posts
well.blogs.nytimes.com

Statins Tied to Lower Risk of Barrett’s Esophagus.

Cholesterol-lowering statin drugs are associated with a lower risk of Barrett's esophagus, a precancerous condition that can sometimes lead to esophageal cancer, a new study has found. Barrett's esophagus is common in people who have long-term gastroesophageal reflux, or GERD. Researchers compared 303 patients with Barrett's esophagus to 909 controls without the syndrome.

Read the article on Well

Dr. Sears Comments:

Dr. Barry Sears

Statins have some anti-inflammatory benefits. But so does an anti-inflammatory diet. When combined with omega-3 fatty acids and polyphenols, you are likely to have a far better benefit in reducing cancer incidence.

Leave a Reply

Your email address will not be published. Required fields are marked *

 |